Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
High invasiveness is a hallmark of human
hepatocellular carcinoma
(
HCC
). Large tumors predict invasion and metastasis. Epithelial-mesenchymal transition (EMT) is crucial for cancer invasion and metastasis. However, the mechanisms whereby large tumors tend to undergo EMT remain unclear. We conducted a subgenome-wide screen and identified
KLHL23
as an
HCC
invasion suppressor by inhibiting EMT.
KLHL23
binds to actin and suppresses actin polymerization.
KLHL23
silencing induced filopodium and lamellipodium formation. Moreover, EMT was suppressed by
KLHL23
through its action on actin dynamics. Traditionally, actin cytoskeleton remodeling is downstream of EMT reprogramming. It is therefore intriguing to ask why and how
KLHL23
inversely regulates EMT. Activation of actin cytoskeleton remodeling by either
KLHL23
silencing or treatment with actin cytoskeleton modulators augmented cellular hypoxic responses in a cell-density-dependent manner, resulting in hypoxia-inducible factor (HIF) and Notch signals and subsequent EMT. Environmental hypoxia did not induce EMT unless actin cytoskeleton remodeling was simultaneously activated and only when cells were at high density. The resulting EMT was reversed by either adenosine 5'-triphosphate supplementation or actin polymerization inhibitors. Down-regulation of
KLHL23
was associated with invasion, metastasis, and poor prognosis of
HCC
and pancreatic cancer. Correlations of tumor size with EMT and inverse association of expression of
KLHL23
with HIF/Notch signals were further validated in patient-derived xenograft HCCs in mice.
...
PMID:Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. 2917 Oct 33